BackEnzon Pharmaceuticals Overview

Enzon Pharmaceuticals Inventory

Track Enzon Pharmaceuticals's inventory ($100M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Inventory
$100.34M

Peer trimmed avg / median

Loading

Enzon Pharmaceuticals Inventory History

Loading

Enzon Pharmaceuticals vs. peers: Inventory Comparison

Loading

Enzon Pharmaceuticals Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Enzon Pharmaceuticals (ENZN) FAQ

Enzon Pharmaceuticals (ENZN) currently reports a inventory of $100M as of September 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Enzon Pharmaceuticals's inventory history and peer comparisons.

Enzon Pharmaceuticals's inventory changed from $0 to $100M (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Enzon Pharmaceuticals reported $100M in inventory as of September 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $100M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Enzon Pharmaceuticals, and consider following ENZN for alerts when major investors trade the stock.

Enzon Pharmaceuticals is classified in the Healthcare sector. On inventory, it currently shows $100M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ENZN with unrelated industries.